- Home
- GIB vs EXEL Comparison
GIB vs EXEL Comparison
Compare GIB & EXEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GIB | EXEL |
|---|---|---|
| Founded | 1976 | 1994 |
| Country | Canada | United States |
| Employees | 94000 | N/A |
| Industry | Professional Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.4B | 12.7B |
| IPO Year | 1999 | 2000 |
Fundamental Metrics
Financial Performance| Metric | GIB | EXEL |
|---|---|---|
| Price | $69.35 | $56.68 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 3 | 21 |
| Target Price | ★ $112.00 | $46.50 |
| AVG Volume (30 Days) | 306.0K | ★ 1.8M |
| Earning Date | 04-29-2026 | 05-05-2026 |
| Dividend Yield | ★ 0.70% | N/A |
| EPS Growth | N/A | ★ 57.95 |
| EPS | N/A | ★ 1.60 |
| Revenue | N/A | ★ $452,477,000.00 |
| Revenue This Year | $8.33 | $13.61 |
| Revenue Next Year | $2.96 | $13.13 |
| P/E Ratio | ★ $13.59 | $36.34 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $59.63 | $33.76 |
| 52 Week High | $95.20 | $59.72 |
Technical Indicators
Market Signals| Indicator | GIB | EXEL |
|---|---|---|
| Relative Strength Index (RSI) | N/A | N/A |
| Support Level | N/A | N/A |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 0.00 | 0.00 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 0.00 | 0.00 |
Price Performance
Historical ComparisonAbout GIB CGI Inc.
CGI is a Canada-based IT-services provider with an embedded position in North America and Europe. The company is one of the major IT suppliers to different levels of government around the world. It offers a broad portfolio of services such as consulting, systems integration, application maintenance, and business process services to governments and the private sector. With offices in over 40 countries, CGI follows a balanced global delivery model with most consultants in client proximity.
About EXEL Exelixis Inc.
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.